Education
About Us
Working with TipRanks
Follow Us
Epigenomics AG (DE:ECX)
:ECX
ECX Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.50 - €2.30
Previous CloseN/A
Volume5.06K
Average Volume (3M)274.00
Market Cap
€482.32K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)966.00K
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Aug 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding876,949
10 Day Avg. Volume657
30 Day Avg. Volume274
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ECX FAQ
What was Epigenomics AG’s price range in the past 12 months?
Epigenomics AG lowest stock price was €0.50 and its highest was €2.30 in the past 12 months.
What is Epigenomics AG’s market cap?
Epigenomics AG’s market cap is €482.32K.
When is Epigenomics AG’s upcoming earnings report date?
Epigenomics AG’s upcoming earnings report date is Aug 06, 2025 which is in 29 days.
How were Epigenomics AG’s earnings last quarter?
Currently, no data Available
Is Epigenomics AG overvalued?
According to Wall Street analysts Epigenomics AG’s price is currently Overvalued.
Does Epigenomics AG pay dividends?
Epigenomics AG does not currently pay dividends.
What is Epigenomics AG’s EPS estimate?
Epigenomics AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epigenomics AG have?
Epigenomics AG has 876,949 shares outstanding.
What happened to Epigenomics AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Epigenomics AG?
Currently, no hedge funds are holding shares in DE:ECX
Epigenomics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Company Description
Epigenomics AG
Epigenomics AG is a molecular diagnostics company, focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, North America, Asia, and the Rest of the world.
Technical Analysis
B.R.A.I.N. Biotechnology Research and Information Network
―
Heidelberg Pharma AG
―
Bio-Gate AG
―
Vitruvia Medical AG
―
SYNLAB AG
―